Fundz

Who to call at LEAP THERAPEUTICS, INC., and when

Fundz watches for the moments LEAP THERAPEUTICS, INC. starts buying, and tells you who to reach.

  • An alert the day LEAP THERAPEUTICS, INC. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at LEAP THERAPEUTICS, INC., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at LEAP THERAPEUTICS, INC.. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
Back to SEC Filings
Executive ChangeItem 5.02 · 8-KMEDIUM RiskMixed

LEAP THERAPEUTICS, INC.

A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.

leaptx.com
Filed: Nov 12, 2025CIK: 0001509745Biotechnology
Full company profileView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Leap Therapeutics, renamed Cypherpunk Technologies Inc. effective November 12, 2025, appointed Khing Oei as non-executive Chairman and William McEvoy as a director, and granted about 5.4 million RSUs under a consulting agreement with CoinXit Ltd., a firm of which Oei is the sole director and employee. The changes signal a shift in board composition and a related-party compensation arrangement that investors should monitor.

Key Takeaways

Khing Oei, sole director and employee of CoinXit Ltd., was appointed Class II director and non-executive Chairman, succeeding Christopher Mirabelli, who remains on the Board.

The Compensation Committee approved a first award of 2,411,700 RSUs to CoinXit under the 2022 Equity Incentive Plan, vesting 12/36ths on October 8, 2026 and 1/36th monthly thereafter.

3 more takeaways

Related Filings (12)

12 more filings from LEAP THERAPEUTICS, INC. in the last 90 days

Filing Overview

Form Type8-K
Filing DateNov 12, 2025
Item5.02
CategoryExecutive Change
CIK0001509745
Accession #0001104659-25-109820
Risk LevelMEDIUM
SentimentMixed
Signalrisk
Topics
board changematerial agreement

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings

LEAP THERAPEUTICS, INC. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

4 screens from a live account. No signup.